Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension symbols : Lly save search
Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma
Published: 2023-11-08 (Crawled : 22:00) - prnewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -0.15%
H: 1.69%
C: 1.54%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.14%
C: -3.81%
biopharma acquire extension
Lilly Announces Extension of Tender Offer to Acquire DICE
Published: 2023-07-25 (Crawled : 12:00) - biospace.com/
DICE | $47.55 0.06% 0.08% 0
|
|
| O: -0.21%
H: 0.15%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.34%
H: 0.69%
C: -0.05%
acquire extension
Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
Published: 2023-01-02 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
RCUS 4 | $14.59 -1.69% 0.0% 600K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
| Email alert
Add to watchlist
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
| Email alert
Add to watchlist
GRTX | $0.1833 -1.45% -1.47% 800K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
treatment cancer pancreatic
TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases
Published: 2022-03-08 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
treatment disease trex media
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
CNTA | $10.555 0.24% 0.24% 150K
|
Manufacturing
|
| O: -8.81%
H: 10.7%
C: -3.99%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
als
Reify Health Powers Patient Recruitment and Enrollment Across AstraZeneca’s Extensive Breast Cancer Clinical Trial Pipeline
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.41%
H: 1.62%
C: 0.11%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.35%
cancer breast cancer trial enroll health
Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Published: 2021-04-06 (Crawled : 23:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.11%
H: 0.51%
C: -1.02%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.3%
H: 1.07%
C: 0.22%
new drug treatment dermatitis drug baricitinib atopic dermatitis